The 11th International Conference of FACO in conjunction with KSMO2023 Congress
FACOセッションは、「大腸癌」および「臨床研究」の２つのテーマで日中韓の研究者がディスカッションし、日本からの演者は西山正彦先生（司会）、沖英次先生（演者）、藤原恵一先生（演者）が参加。
同じ日、第22回FACOビジネス会合も開催し、今後のFACOの方針に関して話し合いが行われました。
The 11th International Conference of FACO was held in conjunction with KSMO2023 Congress at Grand Walkehill Seoul in Korea on 8th September 2023. The same day, the 22nd FACO Business Meeting was held with doctors from three counties.
FACO Session 1：Recent updates in colorectal cancer treatment
Chairs：
Jin Li (FACO Chairman, China)
Young Suk Park (Samsung Medical Center, Republic of Korea)
Speakers:
1. Recent progress in neoadjuvant treatment for locally advanced rectal cancer
Sun Young Kim (Asan Medical Center, Republic of Korea)
2. Does checkpoint inhibitor work in microstallite stable mCRC patients?
Ying Yuan (The Second Affiliated Hospital Zhejiang University School of Medicine, China)
3. Beyond the scalpel: Advancing colorectal cancer management through ctDNA liquid biopsy
Eiji Oki (Kyushu University, Japan)
FACO Session 2: Proposals for new FACO clinical trials
Chairs:
Masahiko Nishiyama (FACO CEO, Higashi Sapporo Hospital, Japan)
Dong-Wan Kim (Seoul National University Hospital, Republic of Korea)
Speakers:
1. Clinical trials: from the viewpoint of lung cancer medical oncologist
Sehhoon Park (Samsung Medical Center, Republic of Korea)
2. Clinical trials: From the viewpoint of a gynecologic oncologist
Ning Li (National Cancer Center/Cancer Hospital (Institute) Chinese Academy of Medical Sciences & Peking Union Medical College, China)
3. International Collaboration in Gynecological Cancer Trials
Keiichi Fujiwara (Saitama Medical University and International University of Health and Welfare, Japan)